Update: DEA responds to WeedPress

Nov. 6, 2026, following DEA’s 4:27, 4:30 and 4:55 p.m. CST replies. The earlier publication-time references to unanswered DEA inquiries should be read with this update.

DEA public information officer Emily Murray wrote at 4:27 p.m.:8

DEA registrants are responsible for exercising due diligence to ensure that their suppliers maintain a valid DEA registration and are authorized to handle the applicable controlled substances.

At 4:30 p.m., DEA Media Affairs referred WeedPress to DOJ’s registration announcement and the timely-applicant guidance in response to the reported warning. It did not expressly confirm or dispute the source’s wording.9

The guidance expressly permits covered transactions involving qualifying timely applicants as well as DEA registrants. Murray’s short email does not discuss that exception; WeedPress is reading it alongside Paragraphs 5–8 of the written guidance, rather than as an announcement that the exception has ended.11

In a 4:55 p.m. reply, DEA said applications leave the timely-applicant list as they are approved or withdrawn and emphasized that the file covers timely applicants. It supplied no named supplier roster or separate producer decision timetable.10 Read the complete substantive DEA responses and unresolved questions →

Sources for this update

8. Email from Emily Murray, Pub. Info. Officer, Drug Enf’t Admin., Omaha & St. Louis Field Divs., to WeedPress, RE: South Dakota inquiry: How DEA-registered dispensaries can identify eligible suppliers without a public list (Nov. 6, 2026, 4:27 p.m. CST) (on file with WeedPress).

9. Email from Drug Enf’t Admin., Media Affs., to WeedPress, RE: Press inquiry for immediate publication: Reported DEA guidance to non-timely South Dakota cannabis operators (Nov. 6, 2026, 4:30 p.m. CST) (referring WeedPress to the DOJ announcement and DEA timely-applicant guidance; on file with WeedPress).

10. Email from Drug Enf’t Admin., Media Affs., to WeedPress, RE: Press inquiry: South Dakota medical marijuana registrations under 21 C.F.R. 1301.13(k) (Nov. 6, 2026, 4:55 p.m. CST) (inline responses to six questions sent Oct. 31; on file with WeedPress).

11. Drug Enf’t Admin., Diversion Control Div., DEA Medical Marijuana Timely Applicant Information ¶¶ 3, 5–8, 11 & disclaimer (Oct. 30, 2026), guidance PDF (downloaded again Nov. 6, 2026 after the agency’s replies; byte-identical to the copy reviewed earlier that day).

Genesis Farms, Pitbull Acres and 605 Cannabis are now on WeedPress’s federal-status tracker with registration confirmations or a report of DEA compliance. For South Dakota patients wondering whether their dispensaries will keep finding suppliers, that is welcome news.1

WeedPress has received confirmation of DEA registration for Genesis Farms and Pitbull Acres. Another South Dakota dispensary reports that 605 supplied its certificates, that it reviewed the files, and that it will do business with 605. WeedPress has not independently reviewed 605’s certificates.12

Those are three businesses worth asking about. The next step is getting the details that turn a company name into a dependable supply arrangement: the covered activity and location, the products available, and the route by which a dispensary can obtain them.

The good news deserves to travel as far as the warning

Another South Dakota dispensary reports reviewing 605 Cannabis’s files and says it will do business with the company. WeedPress has not independently reviewed those certificates.2

That is a useful development. A dispensary that needs suppliers says it has received paperwork from 605 and is prepared to do business with the company. Patients have an interest in hearing that answer, just as they have an interest in hearing the questions that prompted it.

Genesis Farms and Pitbull Acres were already listed as DEA registrants following confirmations supplied to WeedPress earlier Friday. The exact federal activities and locations covered by those registrations remain to be verified. For 605, the tracker identifies the information as a third-party compliance report and states that WeedPress has not independently reviewed the certificates or their scope.1

The companies appear on South Dakota’s establishment list as producers. That state listing identifies cultivation or manufacturing activities; it does not establish the federal activity authorized by a particular certificate. Buyers still need the paperwork for the transaction they intend to make.3

WeedPress will add further businesses as confirmations and documented reports arrive. An unanswered email or an absent name on this tracker is no finding against an operator.

A name is a start. Buyers need the rest of the answer.

A dispensary needs to know whether a supplier can provide the product its patients use, in the quantity needed, on a workable schedule. A favorable federal-status report begins that conversation. It does not answer every purchasing question.

DEA’s written guidance directs buyers to obtain their trading partners’ registration certificates or qualifying application confirmations, verify the relevant state license, and retain the due-diligence records. A timely applicant’s document control number must also be checked through DEA’s website. The guidance warns that trading outside the authorized system can put the buyer’s own federal standing at risk.4

The registration type matters. The federal rule separately describes manufacturers, distributors and dispensers, with different authorized activities. WeedPress has asked DEA about the direct manufacturer-to-dispensary route. That question remains unresolved in this reporting, and the company names in this update should not be read as approval of every possible transaction.5

For Genesis Farms, Pitbull Acres and 605, the most useful additional information would be a wholesale contact, the federal activities and sites covered, whether new dispensary customers are being accepted, and what products can actually be supplied. Those are details WeedPress still needs to establish.

Editorial illustration: a veteran, his wife and adult daughter ask whether his usual medicine can be supplied. A dispensary worker calls a supplier beside a checklist for federal status, available products and delivery timing.

For operators who missed the window, waiting can be expensive

Earlier Friday, WeedPress reported accounts from industry sources that some operators waited to apply and lack timely-applicant status. Those businesses have not been identified or individually verified by WeedPress. The source accounts do not establish which companies hold the manufacturer entries on DEA’s public list.6

The distinction matters because a qualifying timely applicant can conduct covered activity under its state license while its application remains pending. Filing late does not confer that same permission to operate before registration.45

For an operator outside that protection and without the required registration, the reported predicament is painful: suspend the activities requiring federal registration while the application is considered, or continue and risk additional consequences. A business that pauses may still be paying rent, security and other bills without the same revenue coming in.

The industry source quoted in WeedPress’s investigation described a DEA warning that continuing without the necessary status could jeopardize approval. DEA had not substantively confirmed that conversation when the investigation was published. Its written guidance independently explains the register-first requirement and the limits on transactions with late or non-applicants.64

Stopping does not guarantee approval. Continuing does not establish that denial has already occurred. The rule preserves review of public-interest and treaty requirements, and DOJ says manufacturer and distributor applications require additional examination, including inspections, production controls and quota determinations. No individual outcome or approval date has been established here.57

What this changes for patients

The encouraging part is that supplier names are coming into view. A dispensary trying to verify its supply chain now has more specific businesses to ask about and one peer reporting that it has received 605’s paperwork and intends to trade with the company.

What has not yet been established is whether those businesses can replace every affected product, serve every dispensary that may need them, or prevent a particular interruption. WeedPress’s reporting has not established a statewide shortage caused by the DEA warning.

For a patient or family member, the question remains practical: can your dispensary keep getting the product you use? Ask about that product and its expected availability. If a change is anticipated, ask when the business expects to know more.

WeedPress’s live establishment tracker records the confirmations, attributed reports and unanswered inquiries. The DEA investigation documents the federal requirements and reported warning. The patient-access article explains what to ask before a dispensary visit.

Patients deserve the good news as promptly as they receive the warning. Today’s update gives them more information and gives dispensaries more names to pursue. The work now is finding out what those businesses can supply—and helping the people relying on that supply get a straight answer.

Operators with federal-status documentation, wholesale availability or corrections can contact weedpressnewstips@gmail.com. WeedPress withholds registration and application control numbers.

Notes

1. Confirmations of DEA registration for Genesis Farms and Pitbull Acres supplied to WeedPress (Nov. 6, 2026) (on file with publisher); WeedPress, Who Can South Dakota Cannabis Businesses Trade With Federally? DEA Status Tracker and State Establishment List (updated Nov. 6, 2026), tracker. Specific federal activity and location coverage remain unverified. ↩

2. Third-party compliance report supplied to WeedPress (Nov. 6, 2026): another South Dakota dispensary reports reviewing 605’s files and intends to do business with the company. WeedPress has not independently reviewed the certificates. ↩

3. S.D. Dep’t of Health, Medical Cannabis Establishments List (content updated Nov. 2, 2026), establishments list (Genesis Farms cultivation and manufacturing, Box Elder; Pitbull Acres cultivation, Canistota and Sturgis; 605 Cannabis cultivation and manufacturing, Worthing), as reproduced in WeedPress’s tracker. ↩

4. Drug Enf’t Admin., Diversion Control Div., DEA Medical Marijuana Timely Applicant Information ¶¶ 1–8 (Oct. 30, 2026), guidance (downloaded and reviewed Nov. 6, 2026). The guidance explains 21 C.F.R. § 1301.13(a), (k)(7); it states that it does not itself have the force and effect of law. ↩

5. 21 C.F.R. § 1301.13(k), (k)(1), (k)(7) (2026); U.S. Dep’t of Just., AG Order No. 6754-2026, at 27–30 (Apr. 2026), order PDF (registration types, public-interest and treaty review, and timely-applicant provision). See also WeedPress, What Should My South Dakota Dispensary Do Before Nov. 29? A DEA Supplier Checklist (Nov. 2, 2026), checklist (identifying the direct-supply question submitted to DEA). ↩

6. Jason Karimi, DEA Warns South Dakota Cannabis Operators Without Federal Status: “You Should Not Be Operating,” Source Says — In an Industry Told in May the Transition “Should Be Smooth”, WeedPress (Nov. 6, 2026), investigation & sources cited therein (source accounts and request for DEA confirmation; no finding that a named company missed the window). ↩

7. Press Release No. 26-1276, U.S. Dep’t of Just., Off. of Pub. Affs., Justice Department Announces Issuance of Federal Registrations for Medical Marijuana Dispensaries (Oct. 30, 2026; updated Nov. 3, 2026), release (state licensure alone does not confer federal registration; manufacturer and distributor review includes inspections, production controls and quota determinations). ↩

Support independent cannabis reporting

WeedPress is reader-supported. No paywall, no corporate sponsors. If this reporting helped you, a one-time or monthly donation keeps the records requests, court filings and fact-checking going. Donations to WeedPress are not tax-deductible.

Jason Karimi, publisher of WeedPress

Jason Karimi, Publisher

Jason Karimi is the publisher of WeedPress and a medical cannabis patient who has covered cannabis law and policy since 2009.

About the publisher → · Corrections & Right of Reply

Leave a Reply

Latest from WeedPress